例如:"lncRNA", "apoptosis", "WRKY"

Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis.

Clin. Immunol.2018 Dec;197:179-185. Epub 2018 Oct 05
Changliang Xu 1 , Yunjie Miao 2 , Qingmeng Pi 3 , Shouchao Zhu 4 , Furong Li 5
Changliang Xu 1 , Yunjie Miao 2 , Qingmeng Pi 3 , Shouchao Zhu 4 , Furong Li 5

[No authors listed]

Author information
  • 1 Department of Nephrology, The Second Affiliated Hospital, Army Medical University, Chongqing 400037, PR China; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, PR China.
  • 2 Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, PR China.
  • 3 Department of Plastic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200129, China.
  • 4 Nanjing Arsmo Plastic and Aesthestic Hospital, Nanjing 210009, PR China.
  • 5 Department of Nephrology, The Second Affiliated Hospital, Army Medical University, Chongqing 400037, PR China. Electronic address: lifurong1978@163.com.

摘要


Lupus nephritis (LN) is a common and devastating complication caused by systemic lupus erythematosus. In this study, we evaluated the expression and mechanism of Fos-related antigen 2 (Fra-2) in LN. The results showed that Fra-2 was significantly increased in kidney biopsies of LN patients compared with healthy controls and other kidney disease in glomerular podocytes. The MRL/lpr mouse strain is a murine model of lupus, and it was used to study the mechanisms of Fra-2 in LN. The results showed that Fra-2 was expressed in the glomerular podocytes. We investigated the effects of inflammatory stimuli on Fra-2 protein expression in the glomerular podocytes, and found that interferon gamma was most effective at increasing Fra-2 protein expression. Knockdown of Fra-2 using siRNA enhanced the protein expression of nephrin. Therefore, Fra-2 may be a specific drug target for podocyte injury in LN.

KEYWORDS: Fra 2, Kidney injury, Lupus nephritis, MRL/lpr mice, Podocytes